Special Poster Collection

Join Katie Maass, Ph.D., NBC Abstract Screening Committee Chair and several authors in Forum #1 in the Solution Center for a conversation about posters she is especially excited about from Track 1: Advances in Therapeutic Development Across Modalities.

M1330-01-05 Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides, Kevork Mekhssian, MSc, Altasciences

M1430-01-01 Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum, Molly Crowe, Ph.D., PPD Laboratories

M1030-01-04 Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods, Brian Roberts, EpiVax Inc.

T1330-01-03 Harnessing Dendritic Cell Migration as a Predictor of Subcutaneous Immunogenicity Risk in a Mechanism-Based Screening Tool, Nicole Jarvi, University at Buffalo

M1030-01-06 Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study, Rosanna Kwok, Genentech, Inc.

M1330-01-02 A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry, Jane E. Craig, Ph.D., Labcorp Drug Development